Effect of Muscle Strengthening Training in Adults With Fontan Circulation
Primary Purpose
Congenital Heart Disease, Univentricular Heart
Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Individualised muscle strengthening exercise training protocol.
Sponsored by
About this trial
This is an interventional prevention trial for Congenital Heart Disease
Eligibility Criteria
Inclusion Criteria:
- Age minimum 18 years
- Patients: Congenital heart disease (Fontan circulation, univentricle heart)
- Controls: no known congenital heart disease.
Exclusion Criteria:
- Muscle strenghtening exercise training at regular basis (2 times/week or more)
- Active disease or other condition that affect exercise training (e.g. rheumatoid arthritis)
- Cognitive or psychological affection
- Other conditions that affect independent decision-making competence
Sites / Locations
- Umeå University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Adults with Fontan circulation
Healthy controls
Arm Description
Individualised muscle strengthening exercise training protocol.
Individualised muscle strengthening exercise training protocol.
Outcomes
Primary Outcome Measures
Change in muscle oxygenation kinetics evaluated with near-infrared spectroscopy (NIRS).
Muscle oxygenation kinetics will be evaluated with near-infrared spectroscopy (NIRS) (PortaLite mini, Artinis medical system BV, Netherlands). With light in the near infrared spectra it is possible to measure oxygenated and deoxygenated haemoglobin within the muscle. the muscle oxygenation kinetics till be evaluated pre, during and post exercise of muscle endurance in shoulder flexion and heel raise.
Secondary Outcome Measures
Change of isometric muscle strength
Isometric muscle strength in elbow flexion and knee extension will be assessed with a load cell amplifier (VZ101BH 500kg, Anyload Weigh & Measure Inc.,NJ, US). Maximal muscle contraction will be performed during five seconds. The test is repeated three times with a one-minute rest in between. Isometric grip strength will be assessed with a handheld dynamometer (JAMAR, Lafayette, IN, USA). The handle is pressed during three seconds and the test is repeated three times, with a one-minute rest in between. The tests are performed at baseline and at follow up after 10 weeks muscle training exercise protocol.
Change of muscular endurance
Muscle endurance in shoulder flexion will be assessed with a dumbbell (women 2 kg, men 3 kg) and performed in pace with a metronome, 20 contractions per minute (40 beats per minute). Muscle endurance in the calf muscles will be assessed with heel raise with 10 degrees dorsal flexion in the ankle. The test is performed in pace with a metronome with 30 contractions per minute (60 beats per minute). To evaluate muscle endurance in elbow flexion and knee extension, the test person lifts a weight representing 80% of repetition maximum measured at isometric strength. During all tests, the test person performs as many contractions as possible.
Change of muscle mass
Evaluation of muscle mass and muscle density is performed with peripheral quantitative computed tomography (PQCT) which analyse cross section of under arms and lower legs with a low radiation dose (0.01 mSV).
Change of aerobic exercise capacity
Cardiopulmonary exercise tests (CPET) are performed according to standardised protocols with incremental increase of workload. During CPET oxygen and carbon dioxide is measured continuously in the inhaled and exhaled air. Peak watt and peak oxygen uptake capacity (peak VO2) is noted. CPET is used to evaluate the effect of muscle strengthening exercise on the aerobic capacity.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05454254
Brief Title
Effect of Muscle Strengthening Training in Adults With Fontan Circulation
Official Title
Effect of Muscle Strengthening Training in Adults With Fontan Circulation Compared to Healthy Controls
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
August 15, 2022 (Actual)
Primary Completion Date
November 30, 2023 (Anticipated)
Study Completion Date
November 30, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Umeå University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Aim: to evaluate the effect of muscle strengthening exercise training in adults with Fontan circulation compared to healthy controls.
Hypothesis: adults with Fontan circulation have a relatively lower effect of muscle strengthening exercise training compared to healthy controls.
Detailed Description
10 adults with Fontan circulation will be recruited from the clinic specialised in adults with congenital heart disease at Norrlands Universitetssjukhus. In addition, 10 age- and sex matched controls will be recruited. The sample size is estimated according to a previous study with the same primary outcome. We estimate that 7 patients and 7 controls are needed in the study and plan to enrol 10 patients and 10 controls in case of any drop outs.
Muscle tests will be performed at baseline. Based on the results from the muscle tests, an individualised muscle training exercise protocol will be designed and the participants will be working out at a gym during 10 weeks. After 10 weeks the same tests will be performed to evaluate the effect of the muscle training exercise.
In addition to the muscle tests, muscle mass and aerobic exercise capacity will be evaluated with peripheral quantitative computed tomography and cardiopulmonary exercise test respectively. Physical activity will be mapped with a validated questionnaire (IPAQ) and an accelerometer attached to the participants thigh. Any impact on fatigue will be evaluated with a validated questionnaire (MFI-20). All tests and questionnaires will be performed at baseline and at follow-up.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congenital Heart Disease, Univentricular Heart
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Adults with Fontan circulation
Arm Type
Active Comparator
Arm Description
Individualised muscle strengthening exercise training protocol.
Arm Title
Healthy controls
Arm Type
Active Comparator
Arm Description
Individualised muscle strengthening exercise training protocol.
Intervention Type
Other
Intervention Name(s)
Individualised muscle strengthening exercise training protocol.
Intervention Description
Based on the results of muscle function tests at baseline an individualised exercise protocol will be designed.
Primary Outcome Measure Information:
Title
Change in muscle oxygenation kinetics evaluated with near-infrared spectroscopy (NIRS).
Description
Muscle oxygenation kinetics will be evaluated with near-infrared spectroscopy (NIRS) (PortaLite mini, Artinis medical system BV, Netherlands). With light in the near infrared spectra it is possible to measure oxygenated and deoxygenated haemoglobin within the muscle. the muscle oxygenation kinetics till be evaluated pre, during and post exercise of muscle endurance in shoulder flexion and heel raise.
Time Frame
10 weeks
Secondary Outcome Measure Information:
Title
Change of isometric muscle strength
Description
Isometric muscle strength in elbow flexion and knee extension will be assessed with a load cell amplifier (VZ101BH 500kg, Anyload Weigh & Measure Inc.,NJ, US). Maximal muscle contraction will be performed during five seconds. The test is repeated three times with a one-minute rest in between. Isometric grip strength will be assessed with a handheld dynamometer (JAMAR, Lafayette, IN, USA). The handle is pressed during three seconds and the test is repeated three times, with a one-minute rest in between. The tests are performed at baseline and at follow up after 10 weeks muscle training exercise protocol.
Time Frame
10 weeks
Title
Change of muscular endurance
Description
Muscle endurance in shoulder flexion will be assessed with a dumbbell (women 2 kg, men 3 kg) and performed in pace with a metronome, 20 contractions per minute (40 beats per minute). Muscle endurance in the calf muscles will be assessed with heel raise with 10 degrees dorsal flexion in the ankle. The test is performed in pace with a metronome with 30 contractions per minute (60 beats per minute). To evaluate muscle endurance in elbow flexion and knee extension, the test person lifts a weight representing 80% of repetition maximum measured at isometric strength. During all tests, the test person performs as many contractions as possible.
Time Frame
10 weeks
Title
Change of muscle mass
Description
Evaluation of muscle mass and muscle density is performed with peripheral quantitative computed tomography (PQCT) which analyse cross section of under arms and lower legs with a low radiation dose (0.01 mSV).
Time Frame
10 weeks
Title
Change of aerobic exercise capacity
Description
Cardiopulmonary exercise tests (CPET) are performed according to standardised protocols with incremental increase of workload. During CPET oxygen and carbon dioxide is measured continuously in the inhaled and exhaled air. Peak watt and peak oxygen uptake capacity (peak VO2) is noted. CPET is used to evaluate the effect of muscle strengthening exercise on the aerobic capacity.
Time Frame
10 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age minimum 18 years
Patients: Congenital heart disease (Fontan circulation, univentricle heart)
Controls: no known congenital heart disease.
Exclusion Criteria:
Muscle strenghtening exercise training at regular basis (2 times/week or more)
Active disease or other condition that affect exercise training (e.g. rheumatoid arthritis)
Cognitive or psychological affection
Other conditions that affect independent decision-making competence
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Camilla Sandberg
Phone
+46730395773
Email
camilla.sandberg@umu.se
Facility Information:
Facility Name
Umeå University Hospital
City
Umeå
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Camilla Sandberg, PhD
Phone
+46907858441
First Name & Middle Initial & Last Name & Degree
Anna Wikner, MD
Email
anna.wikner@umu.se
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effect of Muscle Strengthening Training in Adults With Fontan Circulation
We'll reach out to this number within 24 hrs